We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BioMarin Pharmaceutical Inc. (BMRN) - free report >>
Anheuser-Busch InBev SA/NV (BUD) - free report >>
Advanced Energy Industries, Inc. (AEIS) - free report >>
Image: Bigstock
New Strong Sell Stocks for March 27th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Advanced Energy Industries, Inc. (AEIS - Free Report) is a manufacturer of power conversion, measurement and control solutions that transform electrical power into various usable forms. The Zacks Consensus Estimate for its current year earnings has been revised 1.3% downward over the last 30 days.
AdvanSix Inc. (ASIX - Free Report) is a manufacturer and seller of polymer resins. The Zacks Consensus Estimate for its current year earnings has been revised 10.9% downward over the last 30 days.
Anheuser-Busch InBev SA/NV (BUD - Free Report) is a producer and distributor of beer, alcoholic beverages, and soft drinks. The Zacks Consensus Estimate for its current year earnings has been revised 0.4% downward over the last 30 days.
BioMarin Pharmaceutical Inc. (BMRN - Free Report) is a developer of therapies for life-threatening rare diseases and medical conditions. The Zacks Consensus Estimate for its current year earnings has been revised 13.1% downward over the last 30 days.
Champions Oncology, Inc. (CSBR - Free Report) is a developer of technology solutions used in personalizing the development and use of oncology drugs. The Zacks Consensus Estimate for its current year earnings has been revised 8.3% downward over the last 30 days.
View the entire Zacks Rank #5 List.